These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6870545)

  • 1. Viral vaccines: the use of currently available products and future developments.
    Norrby E
    Arch Virol; 1983; 76(3):163-77. PubMed ID: 6870545
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic relationships between an isolate of the Western Subtype of tick-borne encephalitis virus and an inactivated vaccine derived from it.
    Lee JM; Stephenson JR
    Vaccine; 1985 Sep; 3(3):292-6. PubMed ID: 2998112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Approaches to the design of antiviral vaccines (a theoretical review)].
    Dzagurov SG; Gnuni GM; Khvoles AG
    Vopr Virusol; 1984; 29(2):137-40. PubMed ID: 6203226
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of virus mutations caused by passages on vaccinal immunogenicity].
    Kato A
    Nihon Rinsho; 2008 Oct; 66(10):1908-14. PubMed ID: 18939489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The status of research to develop new vaccines against infection caused by the respiratory syncytial virus].
    Pervikov IuV; Litvinov SK
    Vopr Virusol; 1988; 33(5):523-9. PubMed ID: 3064426
    [No Abstract]   [Full Text] [Related]  

  • 7. Current status of dengue vaccines and prospects for the future.
    Bancroft WH
    P R Health Sci J; 1987 Apr; 6(1):23-6. PubMed ID: 3615797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular biology of paramyxoviruses and its significance for the development of vaccines].
    Scheid A
    Internist (Berl); 1985 Feb; 26(2):98-102. PubMed ID: 3884533
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent trends in veterinary vaccines.
    Bittle JL
    Prog Clin Biol Res; 1985; 178():621-6. PubMed ID: 4011619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus vaccines.
    Bernstein DI; Stanberry LR
    Vaccine; 1999 Mar; 17(13-14):1681-9. PubMed ID: 10194823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting the stability of viral vaccines.
    Peetermans J
    Dev Biol Stand; 1996; 87():97-101. PubMed ID: 8854006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide vaccines for viral diseases.
    Francis MJ
    Sci Prog; 1990; 74(293 Pt 1):115-30. PubMed ID: 2267573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural protective antigens of viruses used for the development of a new type of chemical vaccines].
    Kostiukov VI; Iarov AI; Zezerov EG
    Vopr Virusol; 1982; (1):5-11. PubMed ID: 7041426
    [No Abstract]   [Full Text] [Related]  

  • 15. Present knowledge of poliovirus and perspectives for future vaccines.
    Crainic R; Blondel B
    Dev Biol Stand; 1987; 66():377-83. PubMed ID: 3034705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in animal and human virus vaccines.
    Rowlands DJ
    Adv Biotechnol Processes; 1986; 6():253-85. PubMed ID: 3535833
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccines: from seed virus to approval].
    Bruhn C
    Dtsch Med Wochenschr; 2009 Nov; 134(48):p44. PubMed ID: 19941270
    [No Abstract]   [Full Text] [Related]  

  • 18. Feline calicivirus: a need for vaccine modification?
    Baulch-Brown C; Love DN; Meanger J
    Aust Vet J; 1997 Mar; 75(3):209-13. PubMed ID: 9088514
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral vaccines: achievements and challenges.
    Melnick JL
    Acta Virol; 1989 Sep; 33(5):482-93. PubMed ID: 2576588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting viral properties for the rational design of modern vaccines.
    Spohn G; Bachmann MF
    Expert Rev Vaccines; 2008 Feb; 7(1):43-54. PubMed ID: 18251693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.